These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 31621974)

  • 41. Evidence of what works to support and sustain care at home for people with dementia: a literature review with a systematic approach.
    Dawson A; Bowes A; Kelly F; Velzke K; Ward R
    BMC Geriatr; 2015 May; 15():59. PubMed ID: 25967742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of community pharmacy-delivered public health interventions on population health and health inequalities: A review of reviews.
    Thomson K; Hillier-Brown F; Walton N; Bilaj M; Bambra C; Todd A
    Prev Med; 2019 Jul; 124():98-109. PubMed ID: 30959070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pragmatic randomised controlled trial (RCT) and realist evaluation of the interdisciplinary home-bAsed Reablement program (I-HARP) for improving functional independence of community dwelling older people with dementia: an effectiveness-implementation hybrid design.
    Jeon YH; Simpson JM; Low LF; Woods R; Norman R; Mowszowski L; Clemson L; Naismith SL; Brodaty H; Hilmer S; Amberber AM; Gitlin LN; Szanton S
    BMC Geriatr; 2019 Jul; 19(1):199. PubMed ID: 31357949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A qualitative study exploring medication management in people with dementia living in the community and the potential role of the community pharmacist.
    Maidment ID; Aston L; Moutela T; Fox CG; Hilton A
    Health Expect; 2017 Oct; 20(5):929-942. PubMed ID: 28105781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A stakeholder co-design approach for developing a community pharmacy service to enhance screening and management of atrial fibrillation.
    Sabater-Hernández D; Tudball J; Ferguson C; Franco-Trigo L; Hossain LN; Benrimoj SI
    BMC Health Serv Res; 2018 Feb; 18(1):145. PubMed ID: 29486758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Supporting underserved patients with their medicines: a study protocol for a patient/professional coproduced education intervention for community pharmacy staff to improve the provision and delivery of Medicine Use Reviews (MURs).
    Latif A; Pollock K; Anderson C; Waring J; Solomon J; Chen LC; Anderson E; Gulzar S; Abbasi N; Wharrad H
    BMJ Open; 2016 Dec; 6(12):e013500. PubMed ID: 27940633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease.
    Blenkinsopp A; Anderson C; Armstrong M
    J Public Health Med; 2003 Jun; 25(2):144-53. PubMed ID: 12848404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WITHDRAWN: Support for carers of people with Alzheimer's type dementia.
    Thompson C; Spilsbury K
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000454. PubMed ID: 17636637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A systematic review of the outcome data supporting the Healthy Living Pharmacy concept and lessons from its implementation.
    Nazar ZJ; Nazar H; White S; Rutter P
    PLoS One; 2019; 14(3):e0213607. PubMed ID: 30861046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A feasibility study of community pharmacists performing depression screening services.
    O'Reilly CL; Wong E; Chen TF
    Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT.
    Lamb SE; Mistry D; Alleyne S; Atherton N; Brown D; Copsey B; Dosanjh S; Finnegan S; Fordham B; Griffiths F; Hennings S; Khan I; Khan K; Lall R; Lyle S; Nichols V; Petrou S; Zeh P; Sheehan B
    Health Technol Assess; 2018 May; 22(28):1-202. PubMed ID: 29848412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the Consolidated Framework for Implementation Research.
    Weir NM; Newham R; Dunlop E; Bennie M
    Implement Sci; 2019 Mar; 14(1):21. PubMed ID: 30832698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developing a core outcome set for people living with dementia at home in their neighbourhoods and communities: study protocol for use in the evaluation of non-pharmacological community-based health and social care interventions.
    Harding AJE; Morbey H; Ahmed F; Opdebeeck C; Wang YY; Williamson P; Swarbrick C; Leroi I; Challis D; Davies L; Reeves D; Holland F; Hann M; Hellström I; Hydén LC; Burns A; Keady J; Reilly S
    Trials; 2018 Apr; 19(1):247. PubMed ID: 29690920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The UK Pharmacy Care Plan service: Description, recruitment and initial views on a new community pharmacy intervention.
    Twigg MJ; Wright D; Kirkdale CL; Desborough JA; Thornley T
    PLoS One; 2017; 12(4):e0174500. PubMed ID: 28369064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knowledge exchange throughout the dementia care journey by Canadian rural community-based health care practitioners, persons with dementia, and their care partners: an interpretive descriptive study.
    Forbes DA; Finkelstein S; Blake CM; Gibson M; Morgan DG; Markle-Reid M; Culum I; Thiessen E
    Rural Remote Health; 2012 Oct; 12(4):2201. PubMed ID: 23176308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interventions for preventing delirium in older people in institutional long-term care.
    Woodhouse R; Burton JK; Rana N; Pang YL; Lister JE; Siddiqi N
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD009537. PubMed ID: 31012953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interventions to enhance access to and utilization of formal community care services for home dwelling persons with dementia and their informal carers. A scoping review.
    Røsvik J; Michelet M; Engedal K; Bieber A; Broda A; Gonçalves-Pereira M; Hopper L; Irving K; Jelley H; Kerpershoek L; Meyer G; Marques MJ; Portolani E; Sjölund BM; Sköldunger A; Stephan A; Verhey F; de Vugt M; Woods B; Wolfs C; Zanetti O; Selbaek G
    Aging Ment Health; 2020 Feb; 24(2):200-211. PubMed ID: 30663890
    [No Abstract]   [Full Text] [Related]  

  • 58. Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes.
    Ocampo CC; Garcia-Cardenas V; Martinez-Martinez F; Benrimoj SI; Amariles P; Gastelurrutia MA
    Int J Clin Pharm; 2015 Oct; 37(5):931-40. PubMed ID: 26040837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0).
    ;
    J Am Pharm Assoc (2003); 2008; 48(3):341-53. PubMed ID: 18595820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interventions to enhance effective communication during over-the-counter consultations in the community pharmacy setting: A systematic review.
    Seubert LJ; Whitelaw K; Hattingh L; Watson MC; Clifford RM
    Res Social Adm Pharm; 2018 Nov; 14(11):979-988. PubMed ID: 29258734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.